Acute Respiratory Distress Syndrome Research Report 2024: Market to Grow at a CAGR of 8.7% During 2025-2030, Driven by Technological Advances in Diagnostics and Therapies Dublin, Oct. 23, 2024 (GLOBE NEWSWIRE) -- The "Global Acute Respiratory Distress Syndrome Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by End-User, Mode of Administration,...

Neonatal Ventilator Market Size is projected to reach USD 681.72 million by 2030, growing at a CAGR of 6.7%: Straits Research New York, United States, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Neonatal ventilators are breathing assistance devices explicitly designed for neonatal patients—the primary method for treating failures...

NeuroRx and Relief Therapeutics Announce Fast Track Designation Granted by the FDA to RLF-100 (Aviptadil) for the Treatment of Respiratory Distress in COVID-19 Fast Track Designation of RLF-100 for the treatment of Acute Lung Injury/Acute Respiratory Distress Syndrome associated with COVID-19 underscores the urgent need for new treatment options for these...

Relief Therapeutics and NeuroRx Expand Clinical Trial of RLF-100 to All Patients with Critical COVID-19 and Respiratory Failure Clinical trial expanded to patients treated with both noninvasive and mechanical ventilation in critical COVID-19Clinical trial to enroll 144 patients total with expansion to additional sites RLF-100...